Analysts/Institutional Investor Meet/Con. Call Updates

11 November, 2026 To, To, The General Manager The Manager Department of Corporate services Listing Department BSE Ltd National Stock Exchange of India Limited, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor, Dalal Street, Plot No.C/1, 'G' Block Mumbai - 400 001. Bandra - Kurla Complex Scrip Code - 543308 Mumbai - 400 051. ISIN: INE967H01025 Symbol - KIMS ISIN: INE967H01025 Dear Sir/ Madam, Sub: Transcript of earnings conference call with Analyst / Investors. With reference to our letter dated 29th October 2026, we wish to inform you that the Company had conducted a conference call with Investors/Analysts on Thursday, 5th November 2026, at 10:00 A.M. (IST). In this regard, please find enclosed herewith a copy of the transcript of the aforesaid conference call. The transcript has also been uploaded on the Company's website at https://www.kimshospitals.com/investors under the following path: Disclosures under Regulation 46 of SEBI (LODR) Regulations, 2015 → Analysts Calls Schedule, PPT & Transcripts → Transcripts, Audio & Video Recordings → FY 2026–27. Kindly take the same on record. Thanking you, Yours truly For Krishna Institute of Medical Sciences Limited Nagajayanthi J. R Company Secretary & Compliance Officer Encl: As above “KIMS Hospital Q2 FY27 Earnings Conference Call” November 05, 2026 MANAGEMENT: DR. BHASKAR RAO BOLLINENI – FOUNDER AND MANAGING DIRECTOR – KIMS HOSPITAL DR. ABHINAY BOLLINENI – EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER – KIMS HOSPITAL MR. SACHIN SALVI – CHIEF FINANCIAL OFFICER – KIMS HOSPITAL DR. NITISH KUMAR – CHIEF EXECUTIVE OFFICER – BANGALORE CLUSTER – KIMS HOSPITAL MR. SREENATH REDDY – HEAD OF BUSINESS DEVELOPMENT– KIMS HOSPITAL MODERATOR: MR. RAHUL JEEWANI – IIFL SECURITIES LIMITED Page 1 of 18 KIMS Hospital November 05, 2026 Moderator: Ladies and gentlemen, good day and welcome to KIMS Hospitals Q2 FY 2027 Earning Conference Call hosted by IIFL Capital. As a reminder, all participant lines will be in the listen- only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing star, then zero on your touch-tone phone. Please note that this conference is being recorded. I now hand the conference over to Mr. Rahul Jeewani from IIFL Capital. Thank you. Over to you, Mr. Jeewani. Rahul Jeewani: Yes. Hi, good morning, everyone. This is Rahul from IIFL Capital. I welcome you all to the second quarter earnings conference call of KIMS Hospitals being hosted by IIFL. From KIMS, we have with us today Dr. Bhaskar Rao Bollineni, Founder and Managing Director, Dr. Abhinay Bollineni, Executive Director and CEO, Mr. Sachin Salvi, CFO, Dr. Nitish Kumar, the CEO for the Bangalore cluster, and Sreenath Reddy, Head of Business Development. Over to you, sir, for your opening comments. Bhaskar Rao Bollineni: Good morning, everyone. We are amidst a hectic festive season that commemorates the patriotic Independence Day, followed by DEVOTIONAL GANESH CHATURTHI, and recently concluded SPIRITUAL NAVRATRI. We are now on the threshold of JOYFUL DIWALI. Let me start the meet by conveying our festive greetings to you. Now I am going to unfold the financial picture of Q2. I am sure the results I am going to announce now will wonderfully blend with the festive fervour. We have recorded a growth under all key parameters, both in quarter-on-quarter and year-on-year basis, with significant rise in revenue. A snapshot of consolidated financial and operational highlights are as follows. Q2 FY 2027 updates:  Total revenue of INR1,363 crores, a growth of 41.3% on year-on-year and 14% on quarter- on-quarter basis.  EBITDA of INR279 crores, a growth of 34% on year-on-year and 16.3% on quarter-on- quarter basis.  EBITDA margin stood at 20.5% versus 20.1% in quarter one FY 2027, and 21.7% in quarter two FY 2026.  PAT at INR76 crores in quarter two, financial year 2027, against INR37 crores and INR72 crores in quarter one FY 2027 and quarter two FY 2026, respectively.  Consolidated EPS for the period ended with 30th September 2026 of INR1.8, a growth of 8.5% on year-on-year basis.  Cash and cash equivalents, including cash, bank balance, deposits with maturity of less than 12 months, and investment in mutual funds of INR420 crores as on 30th September 2026. Page 2 of 18 KIMS Hospital November 05, 2026 Q2 FY 2027 Financial Highlights – Consolidated:  Consolidated revenue from operations of INR1,344 crores, a growth of 39.9% on year-on- year and 14% on quarter-on-quarter basis.  Consolidated EBITDA, pre-Ind AS, of INR250 crores. There is a growth of 24.7% on year- on-year and 12.7% on quarter-on-quarter basis.  Consolidated EBITDA, pre-Ind AS, and excluding other income of INR232 crores, a growth of 17.9% year-on-year, and a growth of 12.6% quarter-on-quarter basis. Operational Highlights Consolidated. Q2 FY27 updates  Average revenue per operating bed grew by 14.9% and 2.3% year-on-year and quarter-on- quarter basis, respectively. Average revenue per patient grew by 9.9% and 1.2% year-on- year and quarter-on-quarter basis.  The IP volumes 81,668 grew 27% year-on-year and 12.7% quarter-on-quarter.  The OP volumes, 731,010 grew 23.3% year-on-year and 11% quarter-on-quarter basis. I would like to apprise you about the acquisitions we have made recently to strengthen our network and growth path. Following are the highlights:  KIMS Trust Hospital, Kakinada, 183 beds, we have acquired 51% of equity stake in Sarvottam Health Care Private Limited. That is Trust Hospital by investing INR80 crores. Now it will be known as the KIMS Trust Hospital. The acquisition holds high potential and prospectus.  Ushahkal Abhinav Specialty Hospital, Sangli, Maharashtra, with 316 beds. We have acquired 6% stake by investing INR15 crores.  KIMS Kompally, Secunderabad, 225 beds.  KIMS Sikhara, Guntur, Andhra Pradesh, 150 beds. The above two acquisitions i.e KIMS Kompally and KIMS Sikhara Guntur will be made over a period of time whenever our internal resources are comfortable.  We have entered into an O&M agreement with the Arete Hospitals in Gachibowli, Hyderabad, which has a bed capacity of 300 beds.  We also entered into O&M agreement with Westfort Hospital in Thrissur, Kerala. It is an established and reputed hospital with a 300-bed capacity. These initiatives will result in increased financial and operational leverages, as all these units hold good potential and prospects. Page 3 of 18 KIMS Hospital November 05, 2026 Our avowed aim and objective have always been to create and multiply the wealth for our investors. The latest acquisitions along with the recent expansions will ensure stable and sustainable growth of high range. Other Highlights Making healthcare available and accessible has been our prime motto. In this connection, we are pleased to state that organ transplantations are performed across even tier two, tier three cities in entire Andhra Pradesh. All these years, transplantations involved long distances as they were performed only at a very few centers.It is no longer so, with all our units spread across the state handling such cases. We have doubled the capacity of our KIMS Saveera Hospital, Anantapur, from 250 to 500 beds. The upgraded hospitals includes a new comprehensive oncology block and a dedicated mother and child block that includes neonatal care facilities, support maternal, newborn, and pediatric services in the hospital. The new buildings and facilities were inaugurated on 1st November 2026 by the Honorable Minister of Health and Honorable Minister of Finance, Government of Andhra Pradesh. Rayalaseema is considered a backward region in the state, and the latest facilities will greatly benefit the people of this region who otherwise were required to travel long distances. International collaboration At the invitation of Honorable Chief Minister of Telangana, recently a high-level delegation from Live [Showing first 8,000 characters — download PDF for full document]